Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.2471
-0.0035 (-1.40%)
At close: Oct 7, 2026, 4:00 PM EDT
0.2499
+0.0028 (1.13%)
After-hours: Oct 7, 2026, 7:43 PM EDT
Vistagen Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Vistagen Therapeutics stock have an average target of $1.00, which predicts a 304.69% increase from the current stock price of 0.25.
Price Target: $1.00 (+304.69%)
Analyst Consensus: Hold
Price Target
Chart* Price targets were last updated on Jul 6, 2026.
Analyst Ratings
The average analyst rating for Vistagen Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Sep 23, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $1 | Hold | Maintains | $1 | +304.69% | Jul 6, 2026 |
Financial Forecast
Revenue This Year
1.70M
from 1.27M
Increased by 33.96%
Revenue Next Year
n/a
from 1.70M
Decreased by -100.00%
EPS This Year
-1.48
from -1.83
EPS Next Year
-1.54
from -1.48
EPS and Forward PE are based on non-GAAP adjusted numbers.